| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 1,150,400 | 1,137,210 | 1,106,690 | 1,124,410 | 874,940 |
| Sales Growth | +1.16% | +2.76% | -1.58% | +28.51% | -12.49% |
| Net Income | 52,740 | -38,600 | -400 | 144,120 | -175,730 |
| Net Income Growth | +236.63% | -9,550.00% | -100.28% | +182.01% | -17,673.00% |
Pro-Assurance Corp (PRA)
23.10 x 35 23.39 x 11
Post-market by (Cboe BZX)
23.33 +0.05 (+0.21%) 03/26/25 [NYSE]
23.10 x 35 23.39 x 11
Post-market 23.38 +0.05 (+0.21%) 16:02 ET
for Wed, Mar 26th, 2025
ProAssurance Corp. operates as a holding company for many property and casualty insurance companies. The company provides professional liability insurance products primarily to physicians, dentists, other healthcare providers and healthcare facilities through its subsidiaries. The company reports primarily through 4 segments: Specialty P&C Insurance segment focuses on professional liability insurance and medical technology liability insurance. Medical technology liability insurance is offered to medical technology and life sciences companies that manufacture or distribute products including entities conducting human clinical trials. Workers' Compensation Segment provides workers' compensation products primarily to employers with 1,000 or fewer employees. Segregated Portfolio Cell Reinsurance unit reflects the operating results of SPCs at Eastern Re and Inova Re, its Cayman Islands SPC operations. The last 2 segments are Lloyd's Syndicate & Corporate Segment.
Fiscal Year End Date: 12/31